Our Events break the mould with innovative formats, networking and business development opportunities
LSX European CEO Forum is a 40-person Chatham House Rule, formatted forum in which CEOs and CFOs from innovative life science companies discuss and shape the future of their sector behind closed doors. They are hollow-square formats and not your standard one-dimensional meeting format meaning all executives engage in meaningful strategic and sector debate and discussion. The forums will address the key industry challenges head-on, providing genuine outcomes for the executives and the sector as a whole.
The mission of the 2-hr European CEO Forum was to provide a unique, powerful and valuable space for the candid sharing of experience between the sector’s most senior executives so that they can leave with new ideas that will drive their businesses and the sector forward. This was specifically aimed at companies located in France, Germany, Netherlands, Belgium, Austria, Switzerland, Italy and Spain.
The 5th annual Biotech and Money / Medtech and Money World Congress is a high-calibre, senior Executive, three-day conference and partnering event providing the education, strategies, solutions and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.
Biotechs and the City is a networking event for senior life science executives organised by Biotech and Money. The 3hr evening function serves as an informal forum for up to 70 executives to come together, network and enjoy a relaxed evening with their peers and protégés, together with timely and pertinent presentations or panels.
Spring - 30th March 2017
Summer - 12th July 2017
Autumn - 28th September 2017
Winter - 30th November 2017
Showcasing innovative investable life science and healthcare investment and partnering opportunities. Biotech and Money connects corporates to capital and the Inv€$tival Showcase is our most direct way of showcasing the latest innovative and investable private and public life science opportunities to our investor network.
The HealthEx World Forum is a dynamic, outcome oriented summit for C-suite and board level executives from the worlds of pharma, health technology, finance, and government, dedicated to finding solutions to the health industry’s most pressing challenges through debate, dialogue and collaboration. We aim to be the Davos for Life Sciences.
In line with our mission to address the funding, financing and investment challenges of the world’s most innovative healthcare companies, Biotech and Money is teaming up with some of the world’s foremost experts, advisers, bankers and consultants to help CEOs and CFOs navigate the how, what, where and when of a successful IPO.
Biotech and Money London CEO Forum is where CEOs of listed, and soon to be listed life science and healthcare companies debate the strategies for investor engagement; problem solvechallenges around capital and come together to share ideas on how to promote and cultivate a strong and vibrant environment for life science investment.
Family Offices are, by design, a much more private group than other investors. Interestingly, there is a growing trend of family offices investing in life science companies, and of companies looking to access family office capital.
Family Office investment can be widely viewed as patient capital and there is a growing interest from life science companies inexploring this route to capital due to how investments may be philanthropically (or indeed personally) motivated.
On the 27th June, we spoke to an expert panel to discuss the how, when, what and where of a successful IPO. In this on-demand webinar a panel of expert partners, including KPMG, Covington & Burling and Zeus Capital, answer the key questions that any pre-IPO life science company should know the answers to.